New Products

WOONSOCKET, R.I. — CVS Caremark’s MinuteClinic has announced that it is switching from its own proprietary electronic medical record solution to Epic’s EpicCare system.

"EpicCare's rich platform will allow us to continue to provide the highest quality of care and advance our services through a robust, world class EMR," said Andrew Sussman, president of MinuteClinic and SVP/associate chief medical officer of CVS Caremark.

PRINCETON, N.J. — Kremers Urban Pharmaceuticals, a subsidiary of UCB, announced the launch of rabeprazole sodium delayed-release tablets. The drug is used to treat gastroesophageal reflux disease in adults and adolescents, according to the FDA.

The product is the bioequivalent to Aciphex from Eisai. Kremers Urban rabeprazole sodium delayed-release tablets are available in 20-mg strength in both 30- and 90-count bottles.

NEW YORK — The Food and Drug Administration recently approved two "robotic pills," or pills that place an image camera or ingestible sensors into the gastrointestinal tract, according to a report published earlier this week by the Wall Street Journal. 

Other robotic pills still in development include one backed by Google — a pill that would replace injectable drugs, the report noted. 

COLUMBIA, Md. — FLAVORx, a supplier of custom flavoring systems, announced that it will partner with more than 150 pharmacy schools and pharmacy technician programs to bring flavoring to classrooms and labs.

Faculty members that are currently using FLAVORx systems are pleased with the results, the company said.

CINCINNATI — Procter & Gamble has reportedly developed the first smartphone-connected toothbrush to give consumers personalized advice for better oral health, according to a Reuters report.

The toothbrush, which is slated to launch in June under the Oral-B brand, was unveiled during the Mobile World Congress last week in Barcelona, Reuters reported.

EDISON, N.J. — Certain Dri antiperspirant has raised the bar on perspiration control with the introduction of a thicker, drip-free formulation — Certain Dri Clinical Strength Anti-Perspirant Roll-On.

Combined with a new logo and updated packaging, the new formulation will continue to offer the same 72-hours of sweat protection. This has been the brand’s core benefit in helping the millions of adults and teens who suffer from axillary hyperhidrosis (excessive underarm perspiration), or, who believe their perspiration is a problem.

Where is pharmacy technology headed, and how will it be put to use by pharmacists and the companies that employ them?

NORTH WALES, Pa. — Teva Pharmaceuticals announced the introduction of moxifloxacin hydrochloride tablets, the generic equivalent to Avelox tablets. The drug is available in 400-mg strength.

Moxifloxacin hydrochloride is used to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria, the company said.